Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Divis Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value(
)
532488
INE361B01024
513.6236355
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
DIVISLAB
86.67
159224.07
EPS(TTM)
Face Value(
)
Div & Yield %:
69.2
2
0.5
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
7665.00
7625.00
8879.82
6798.61
5310.57
4879.66
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
7665.00
7625.00
8879.82
6798.61
5310.57
4879.66
Other Income
337.00
349.00
111.26
62.53
189.86
156.58
Stock Adjustments
127.00
-50.00
449.99
100.00
94.10
244.22
Total Income
8129.00
7924.00
9441.07
6961.14
5594.53
5280.46
EXPENDITURE :
Raw Materials
3270.00
3035.00
3499.18
2416.47
2223.95
2120.64
Power & Fuel Cost
477.00
496.00
390.05
319.15
280.73
248.78
Employee Cost
1067.00
953.00
926.55
808.68
608.36
530.72
Other Manufacturing Expenses
299.00
285.00
255.38
202.29
184.36
138.96
Selling & Administrative Expenses
367.00
402.00
340.16
292.53
222.86
171.84
Miscellaneous Expenses
137.00
55.00
40.95
37.69
68.00
62.87
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5617.00
5226.00
5452.27
4076.81
3588.26
3273.81
Operating Profit
2512.00
2698.00
3988.80
2884.33
2006.27
2006.65
Interest
4.00
2.00
1.73
1.81
7.03
4.61
Gross Profit
2508.00
2696.00
3987.07
2882.52
1999.24
2002.04
Depreciation
376.00
342.00
310.55
254.65
185.95
168.81
Profit Before Tax
2132.00
2354.00
3676.52
2627.87
1813.29
1833.23
Tax
511.00
438.00
637.20
609.05
387.79
472.45
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
45.00
108.00
90.78
64.10
52.79
28.13
Reported Net Profit
1576.00
1808.00
2948.54
1954.72
1372.71
1332.65
Extraordinary Items
0.74
3.07
-1.65
-2.45
41.46
18.78
Adjusted Net Profit
1575.26
1804.93
2950.19
1957.17
1331.25
1313.87
Adjustment below Net Profit
-1.00
2.00
2.18
0.16
-92.52
-53.52
P & L Balance brought forward
10922.00
9967.00
7588.31
5814.44
5636.87
4761.92
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
772.00
855.00
571.50
181.01
1102.62
404.18
P & L Balance carried down
11725.00
10922.00
9967.53
7588.31
5814.44
5636.87
Dividend
0.00
0.00
0.00
0.00
424.75
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
1500.00
1500.00
1500.00
1000.00
800.00
800.00
Dividend Per Share(Rs)
30.00
30.00
30.00
20.00
16.00
16.00
Earnings Per Share-Unit Curr
59.47
68.23
111.08
73.64
51.71
50.20
Earnings Per Share(Adj)-Unit Curr
59.47
68.23
111.08
73.64
51.71
50.20
Book Value-Unit Curr
508.83
479.43
440.44
349.28
275.63
262.70
Book Value(Adj)-Unit Curr
508.83
479.43
440.44
349.28
275.63
262.70